Wall Street Is Bullish on the Right Ph.Ds

As science spawns a growing number of technically sophisticated industrial and consumer goods, some financial houses have been hiring scientists to help analyze the products and their markets. "Our approach is simple," said William Welty, managing director of research for Hambrecht & Quist, based in San Francisco. "We look for Ph.D.s to analyze those industries where rapid scientific advances will make a major difference to the success or failure of its companies. A classic case right now is bio

| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

"Our approach is simple," said William Welty, managing director of research for Hambrecht & Quist, based in San Francisco. "We look for Ph.D.s to analyze those industries where rapid scientific advances will make a major difference to the success or failure of its companies. A classic case right now is biotechnology."

Welty also recruits research analysts with doctorates in such areas as mathematics, physics and chemistry. But Daniel Nelson, director of research for Cable Howse & Regan in Seattle, said the need for science expertise among financial analysts is largely restricted to the health sciences.

"Our analyst in biotechnology has a Ph.D. and we just hired a person with a Ph.D. in pharmacology," Nelson observed. The reason: only analysts with a Ph.D.-level knowledge of advanced biotech research can truly understand what the companies are working on, he believes. Such knowledge also is needed to evaluate whether a company's products have ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • John Makulowich

    This person does not yet have a bio.

Published In

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo
Characterizing Immune Memory to COVID-19 Vaccination

Characterizing Immune Memory to COVID-19 Vaccination

10X Genomics
Optimize PCR assays with true linear temperature gradients

Applied Biosystems™ VeriFlex™ System: True Temperature Control for PCR Protocols

Thermo Fisher Logo

Products

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo